| AIDS | Acquired Immunodeficiency Syndrome |
| Alum | Aluminum hydroxide gel adjuvant |
| ALVAC | Canarypox virus vector |
| Ad26/Ad5 | Adenovirus serotype 26/5 vectors |
| bnAb | Broadly neutralizing antibody |
| Env | Envelope |
| eOD-GT8 | Engineered Outer Domain-Germline Targeting 8 |
| Gag | Group-specific antigen |
| gp120 | Glycoprotein 120 |
| HIV | Human immunodeficiency virus |
| HVTN | HIV Vaccine Trials Network |
| IAVI | International AIDS Vaccine Initiative |
| LNP | Lipid nanoparticle |
| MF59 | Oil-in-water emulsion adjuvant |
| MSM | Men who have sex with men |
| Nef | Negative factor |
| Pol | Polymerase |
| PrEP | Pre-exposure prophylaxis |
| VRC01 | Vaccine Research Center 01 antibody (specific bnAb) |